Financial Ratios

THEMIS MEDICARE LTD.

NSE : THEMISMEDBSE : 530199ISIN CODE : INE083B01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE219.00-3.35 (-1.51 %)
PREV CLOSE ( ) 222.35
OPEN PRICE ( ) 224.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25734
TODAY'S LOW / HIGH ( )218.35 224.20
52 WK LOW / HIGH ( )109 266
NSE218.60-4.65 (-2.08 %)
PREV CLOSE( ) 223.25
OPEN PRICE ( ) 224.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 78647
TODAY'S LOW / HIGH( ) 217.00 224.30
52 WK LOW / HIGH ( )110 263.85
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)47.0466.9128.9717.32-13.83
   CEPS(Rs)5.847.723.832.63-0.51
   DPS(Rs)5.005.004.301.750.00
   Book NAV/Share(Rs)306.17264.39201.81172.86155.48
   Tax Rate(%)26.5126.6617.4511.6212.64
Margin Ratios
   Core EBITDA Margin(%)19.0424.2421.6317.701.40
   EBIT Margin(%)19.3223.4919.4915.32-1.47
   Pre Tax Margin(%)16.6321.2713.988.93-7.89
   PAT Margin (%)12.2215.6011.547.89-6.90
   Cash Profit Margin (%)15.1818.0015.2511.99-2.56
Performance Ratios
   ROA(%)10.0216.728.075.18-4.38
   ROE(%)16.4928.7215.4710.55-8.51
   ROCE(%)19.6831.2716.9812.77-1.18
   Asset Turnover(x)0.821.070.700.660.63
   Sales/Fixed Asset(x)1.712.161.441.371.28
   Working Capital/Sales(x)2.803.723.957.6145.39
Efficiency Ratios
   Fixed Capital/Sales(x)0.580.460.690.730.78
   Receivable days126.8682.73143.05159.42140.65
   Inventory Days66.8455.1889.1997.41102.03
   Payable days130.5887.29164.75227.21202.46
Valuation Parameters
   PER(x)24.7913.959.6813.860.00
   PCE(x)19.9612.097.329.12-57.68
   Price/Book(x)3.813.531.391.391.91
   Yield(%)0.430.541.530.730.00
   EV/Net Sales(x)3.242.311.381.561.90
   EV/Core EBITDA(x)14.528.915.948.0466.59
   EV/EBIT(x)16.749.827.0710.19-129.23
   EV/CE(x)2.462.290.940.981.20
   M Cap / Sales3.032.181.121.091.48
Growth Ratio
   Net Sales Growth(%)-10.2171.0714.439.49-12.12
   Core EBITDA Growth(%)-22.7390.9936.66643.70-81.64
   EBIT Growth(%)-26.15106.2145.581238.56-112.76
   PAT Growth(%)-29.67131.2467.30225.33-236.59
   EPS Growth(%)-29.69130.9567.29225.23-236.59
Financial Stability Ratios
   Total Debt/Equity(x)0.330.320.460.630.57
   Current Ratio(x)1.851.861.461.171.03
   Quick Ratio(x)1.391.371.000.850.68
   Interest Cover(x)7.1610.573.542.40-0.23
   Total Debt/Mcap(x)0.090.090.330.450.30

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.